John Lee

Group Leader @UQMedicine @Neuroimmunomics investigating the role of our immune system in brain diseases 🧠

[Neuroimmunomics Lab @neuroimmunomics]

Calling all complementologists! 🚨

The deadline for the @SvarLifeScience Research Excellence Award is approaching soon.

If you are an enthusiastic complementologist with a strong track record in research excellence, I strongly encourage you to apply.
#Complement #Immunology

[Neuroimmunomics Lab @neuroimmunomics]

Our team “Johnny Walker” out at the Walk to Defeat MND - Brisbane! Always great to see such a big crowd rallying behind a vital cause. 💙

@MNDQueensland #WalktoDefeatMND #MotorNeuroneDisease #MND #ALS @QldBrainInst @UQHealth

[Neuroimmunomics Lab @neuroimmunomics]

Feeling sweet about this one 🍭 Our new STAR Protocol is out! From tolerance tests to immunofluorescence and MALDI imaging, we detail how to assess glucose homeostasis in mice 🐭

Sweet details here: https://t.co/U1jAtf57Bw

@TeaTayaaa @Cedric_Cui @JohnDGLee

[Queensland Brain Institute, UQ @QldBrainInst]

QBI welcomes Dr John Lee, our new Ross Maclean Senior Research Fellow whose translational research into motor neurone disease (MND) has already reached clinical testing.

A compound he began studying during his PhD in 2009 recently completed Phase 1B trials after more than 15 years of development. He is also collaborating with a New Zealand company to design liquid drug formulations tailored for MND patients who lose the ability to swallow.

The Ross Maclean Fellowship established by Jeff Maclean AM in memory of his father, Index Group founder Ross Maclean who lost his battle with MND in 2005, offers crucial support to advance these ambitious projects.

“Funding is always scarce in research – this fellowship gives me the opportunity to push drug programs closer to clinical trials while also collaborating with QBI neuroscientists on new discovery-based ideas,” says Dr Lee.

Read more: https://t.co/6EoewCOHpJ

#UQ #QBI #MND #motorneurondisease #neuroscience #fightmnd

[Neuroimmunomics Lab @neuroimmunomics]

@Cedric_Cui @alanajulianisya @marallag_nina @IntlComplement Our wonderful students, Titaya Lerskiatiphanich, @marallag_nina, @grace_risby, and @alanajulianisya
with their posters. Definitely worth comple-menting! 😎

#ICW2025 @IntlComplement

[Neuroimmunomics Lab @neuroimmunomics]

Our post-doc @Cedric_Cui, and students @alanajulianisya @marallag_nina and Austin Read had the opportunity to present their work in some oral presentations 🙌

#ICW2025 @IntlComplement

[Neuroimmunomics Lab @neuroimmunomics]

We had some great representation with @neurocomplement at the International Complement Workshop 2025! #ICW2025 @IntlComplement

[Neuroimmunomics Lab @neuroimmunomics]

Excited to announce our group leader @JohnDGLee has been awarded the Ross Maclean Senior Research Fellowship at @QldBrainInst!

We are so excited to continue our research on #MotorNeuronDisease at #QBI - read more👇🏻

https://t.co/EZFHb3ZE25

#MND #UQ @UQ_News

[Svar Life Science @SvarLifeScience]

Congratulations to Dr. John Lee and Prof. Simon J. Clark recipients of the 2025 Svar Complement Excellence Award, presented at the International Complement Workshop in Brisbane
#ComplementSystem #ICW2025 #ComplementingLifeScience #ComplementExcellenceAward

[Neuroimmunomics Lab @neuroimmunomics]

Our group leader @JohnDGLee had the opportunity to present at @QldBrainInst yesterday 🙌

The seminar was a short (but sweet!) summary on our research in #MotorNeuroneDisease & our lab’s vision. Check out this lovely slide summarising our work - and the people behind it👇

[Neuroimmunomics Lab @neuroimmunomics]

🚨 New publication alert!
Our latest study shows IL-6 trans-signalling drives TDP-43–induced inflammation in MND across both central and peripheral immune cells.
💡 Highlights a promising therapeutic target
Read: https://t.co/N5WR90Ai7e
#MND #ALS @UQMedicine @FightMND

[Neuroimmunomics Lab @neuroimmunomics]

🎉 Another outstanding achievement! Our brilliant PhD student, Alana @alanajulianisya, has been recognised with the Best Poster Award at the Neuroimmunology Australia Workshop. Keep up the exceptional work on MND, Alana! 👏
#NeuroimmunologyAustralia @NeuroimmOZ #MNDResearch

[Neuroimmunomics Lab @neuroimmunomics]

Our team “Johnny Walker 4 MND Trentment” walking in support of @MNDQueensland today. A great crowd, rallying behind a vital cause! 💙

#WalkToDefeatMND #MND #ALS @UQMedicine

[Neuroimmunomics Lab @neuroimmunomics]

🎉 Exciting start to 2025! Huge congratulations to our talented PhD student, Alana Julianisya, for winning the International Complement Society @intlcomplement Early Career Cover Image Award! 🏆

Check out the stunning cover image featuring in our profile! 📸#ResearchExcellence

[Aegean Conferences @AegeanConf]

Speakers Posted: 17th Int'l Conference on #ComplementTherapeutics held in #Sissi, #Crete, #Greece from May 10-15, 2025 @KalimeraKriti organized by @LambrisJD @dmastellos @roumenina https://t.co/72C0EufeFY

[John D. Lambris, Ph.D. @LambrisJD]

This year's Aegean Conference on Complement Therapeutics features a speaker roster that promises to engage the audience, fostering a productive scientific debate and cross-pollination of ideas across diverse disciplines. A great mix of leading experts and emerging talent in different aspects of complement biochemistry, structure-guided drug design, pathobiology and therapeutics (https://t.co/76yEOc5pSt). Graduate students and postdoc are strongly encouraged to submit their work and apply for our generous travel awards. We thank all of our speakers for accepting our invitation and look forward to welcoming you all to Sissi, Crete in May 2025.

[Neuroimmunomics Lab @neuroimmunomics]

Our PhD candidate Titaya presenting at last month’s UQ MND Collective Journal Club. Some thoughtful discussions about peripheral immune cells and their potential involvement in MND. Many thanks to @AndrewTosolini for organising 🙌.

#MND #ALS

[Neuroimmunomics Lab @neuroimmunomics]

Congratulations to our group leader @JohnDGLee for receiving the @FightMND Bill Guest mid-career fellowship. Excited for the next 4 years ahead! 🎉👏

#MND #ALS

[NeuroComplement_Lab @neurocomplement]

3/3 Our data support the outstanding work of @LionakisLab Could this cell-intrinsic complement response be harnessed using therapeutics to fight infection? We are embarking on this question now @JohnDGLee @JennyNFung @UQMedicine

[NeuroComplement_Lab @neurocomplement]

2/3 Xaria demonstrates human macrophages respond bidirectionally to C5a in synergy with a multitude of pathogen molecular triggers. Surprisingly, non TLR PRRs show the greatest enhancement of cytokine release with C5a receptor activation (eg. Dectin-1 / cGAS-STING)